Inovio Pharmaceuticals (INO) Stock: Buy, Sell, or Hold?
$1.50
+0.02 (+1.46%)
▲
5d:
+3.21%
30d:
+51.78%
90d:
+37.3%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (21%)
Quality Score
32/100
Position
EXTENDED
30-Day Fair Range
$0.84 – $1.45
Position: EXTENDED
Forward P/E & Valuation
-3.5x
Next 12M consensus est.
Wall Street Target
$7.00
+374.6% upside
Options IV & Volume
MODERATE Vol
MODERATE volume confirmation
Support / Resistance
$0.60 / $2.17
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: INO shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When INO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: INO is currently trading at $1.50, which is considered extended relative to its 30-day fair value range of $0.84 to $1.45.
Technical Outlook: Technically, INO is in a downtrend. Immediate support is located at $0.60, while resistance sits at $2.17.
Market Sentiment: INO scores 3/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $7.00 (+374.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, INO is in a downtrend. Immediate support is located at $0.60, while resistance sits at $2.17.
Market Sentiment: INO scores 3/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $7.00 (+374.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.84 -
$1.45
Company Quality Score
32/100
(SELL)
Volume Confirmation
MODERATE
Confidence Score
21.1%
Trading Range & Key Levels
30-Day Trading Range
$0.84 -
$1.45
Current vs Trading Range
EXTENDED
Support Level
$0.60
Resistance Level
$2.17
Current Trend
Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (3/100)
- BULLISH: Trading 374.6% below Wall St target ($7.00)
- WARNING: Composite score 32/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-3.51
Wall Street Target
$7.00
(+374.6%)
Revenue Growth (YoY)
-100.0%
Share INO Analysis
Share this live INO analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (INO)
Bullish
19 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
18 msgs
24h retail stream
Last Tracked
Nov 12, 2026
Daily AI digest
AI Retail Discussion Summary:
INOVIO announced participation in two upcoming investor conferences where members of its management team will present and conduct one-on-one meetings with investors.
Key Retail Themes:
Company Updates
Investor Relations
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 2:35 PM ET
Data refreshes hourly during market hours. Next update: 3:35 PM
Data refreshes hourly during market hours. Next update: 3:35 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 37 SELL |
|
ARGX
argenx NV ADR |
STRONG BUY
23 analysts |
$1147 | 31 SELL |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 41 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
18 analysts |
$139 | 41 HOLD |
|
SYRE
Spyre Therapeutics Inc. |
STRONG BUY
18 analysts |
$122 | 44 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive INO Research Pages
